Qingan Jia

1.3k total citations
46 papers, 878 citations indexed

About

Qingan Jia is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Qingan Jia has authored 46 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Immunology. Recurrent topics in Qingan Jia's work include Connective Tissue Growth Factor Research (10 papers), Cancer Mechanisms and Therapy (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Qingan Jia is often cited by papers focused on Connective Tissue Growth Factor Research (10 papers), Cancer Mechanisms and Therapy (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Qingan Jia collaborates with scholars based in China, Ethiopia and Czechia. Qingan Jia's co-authors include Xia Liao, Yang Bu, Qiangbo Zhang, Lun–Xiu Qin, Zhenggang Ren, Tong‐Chun Xue, Qiongzhu Dong, Boheng Zhang, Quanbao Zhang and Fang Liu and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Qingan Jia

45 papers receiving 869 citations

Peers

Qingan Jia

ONCOL

IMMUN

HEPAT

Jinghua Jiang China

Qi Shen China

Rui Feng China

Xingrong Guo China

Junfeng Wang China

Rirong Yang China

Wei Gong China

Lianjie Lin China

Guangming Li China

Jinghua Jiang China

Qingan Jia

334 ×0.8

154 ×0.7

ONCOL

158 ×0.8

121 ×0.7

IMMUN

114 ×1.0

HEPAT

Citations per year, relative to Qingan Jia Qingan Jia (= 1×) peers Jinghua Jiang

Countries citing papers authored by Qingan Jia

Since Specialization

Citations

This map shows the geographic impact of Qingan Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingan Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingan Jia more than expected).

Fields of papers citing papers by Qingan Jia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingan Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingan Jia. The network helps show where Qingan Jia may publish in the future.

Co-authorship network of co-authors of Qingan Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Qingan Jia. A scholar is included among the top collaborators of Qingan Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingan Jia. Qingan Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ye, Zixuan, Aibin He, Qingan Jia, et al.. (2024). An engineered α1β1 integrin-mediated FcγRI signaling component to control enhanced CAR macrophage activation and phagocytosis. Journal of Controlled Release. 377. 689–703. 32 indexed citations

Song, Yuna, et al.. (2023). Magnesium metal and its corrosion products: Promising materials for tumor interventional therapy. Journal of Magnesium and Alloys. 11(3). 763–775. 30 indexed citations

Jia, Qingan, Xia Liao, Tian Fan, et al.. (2023). Inositol hexaphosphate enhances chemotherapy by reversing senescence induced by persistently activated PERK and diphthamide modification of eEF2. Cancer Letters. 582. 216591–216591. 3 indexed citations

Guan, Min, et al.. (2023). Effects of Transplantation and Microhabitat on Rhizosphere Microbial Communities during the Growth of American Ginseng. Agronomy. 13(7). 1876–1876. 3 indexed citations

Jia, Qingan, et al.. (2022). Anti-Tumor Role of CAMK2B in Remodeling the Stromal Microenvironment and Inhibiting Proliferation in Papillary Renal Cell Carcinoma. Frontiers in Oncology. 12. 740051–740051. 11 indexed citations

Liao, Xia, et al.. (2021). OSCAR facilitates malignancy with enhanced metastasis correlating to inhibitory immune microenvironment in multiple cancer types. Journal of Cancer. 12(13). 3769–3780. 6 indexed citations

Jia, Qingan, et al.. (2021). CCN Family Proteins in Cancer: Insight Into Their Structures and Coordination Role in Tumor Microenvironment. Frontiers in Genetics. 12. 649387–649387. 27 indexed citations

Liao, Xia, Zihan Xu, Fan Chang, et al.. (2020). WISP1 Predicts Clinical Prognosis and Is Associated With Tumor Purity, Immunocyte Infiltration, and Macrophage M2 Polarization in Pan-Cancer. Frontiers in Genetics. 11. 502–502. 16 indexed citations

Xu, Zihan, et al.. (2020). Estrogen protects against liver damage in sepsis through inhibiting oxidative stress mediated activation of pyroptosis signaling pathway. PLoS ONE. 15(10). e0239659–e0239659. 29 indexed citations

10.

Liao, Xia, Ge Song, Zihan Xu, et al.. (2020). Oxaliplatin resistance is enhanced by saracatinib via upregulation Wnt-ABCG1 signaling in hepatocellular carcinoma. BMC Cancer. 20(1). 31–31. 26 indexed citations

11.

Liao, Xia, Shanshan Jiang, Fan Chang, et al.. (2019). CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma. Hepatology International. 13(4). 440–453. 16 indexed citations

12.

Jia, Qingan, Tong‐Chun Xue, Qiangbo Zhang, et al.. (2017). CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma. Scientific Reports. 7(1). 13846–13846. 10 indexed citations

13.

Jia, Qingan, et al.. (2017). Maintenance of stemness is associated with the interation of LRP6 and heparin-binding protein CCN2 autocrined by hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 36(1). 117–117. 24 indexed citations

14.

Liu, Fang, et al.. (2016). Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma. PLoS ONE. 11(11). e0165681–e0165681. 53 indexed citations

15.

Zhang, Quanbao, Qingan Jia, Yang Bu, et al.. (2015). Herbal Compound Songyou Yin and Moderate Swimming Suppress Growth and Metastasis of Liver Cancer by Enhancing Immune Function. Integrative Cancer Therapies. 15(3). 368–375. 28 indexed citations

16.

Xue, Tong‐Chun, Qingan Jia, Ningling Ge, et al.. (2015). Imbalance in systemic inflammation and immune response following transarterial chemoembolization potentially increases metastatic risk in huge hepatocellular carcinoma. Tumor Biology. 36(11). 8797–8803. 21 indexed citations

17.

Xue, Tong‐Chun, Qingan Jia, Yang Bu, et al.. (2014). CXCR7 correlates with the differentiation of hepatocellular carcinoma and suppresses HNF4α expression through the ERK pathway. Oncology Reports. 32(6). 2387–2396. 16 indexed citations

18.

Zhang, Qiangbo, Hui‐Chuan Sun, Kezhi Zhang, et al.. (2013). Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma. PLoS ONE. 8(2). e55945–e55945. 45 indexed citations

19.

Ren, Zhenggang, et al.. (2013). Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma. BMC Cancer. 13(1). 363–363. 19 indexed citations

20.

Jia, Qingan, Zhiming Wang, Zhenggang Ren, et al.. (2013). Herbal compound “Songyou Yin” attenuates hepatoma cell invasiveness and metastasis through downregulation of cytokines secreted by activated hepatic stellate cells. BMC Complementary and Alternative Medicine. 13(1). 89–89. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact